The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 06, 2021
Filed:
Apr. 07, 2020
Applicants:
Incyte Corporation, Wilmington, DE (US);
Incyte Holdings Corporation, Wilmington, DE (US);
Inventors:
Liangxing Wu, Wilmington, DE (US);
Colin Zhang, Berwyn, PA (US);
Chunhong He, Boothwyn, PA (US);
Liang Lu, Hockessin, DE (US);
Wenqing Yao, Chadds Ford, PA (US);
Assignees:
Incyte Corporation, Wilmington, DE (US);
Incyte Holdings Corporation, Wilmington, DE (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 471/14 (2006.01); C07D 495/14 (2006.01); C07D 471/20 (2006.01); C07D 498/14 (2006.01); C07D 498/22 (2006.01); C07D 471/22 (2006.01); C07D 491/22 (2006.01); A61P 1/16 (2006.01); A61P 11/00 (2006.01); A61P 19/02 (2006.01);
U.S. Cl.
CPC ...
C07D 471/14 (2013.01); A61P 1/16 (2018.01); A61P 11/00 (2018.01); A61P 19/02 (2018.01); C07D 471/20 (2013.01); C07D 471/22 (2013.01); C07D 491/22 (2013.01); C07D 495/14 (2013.01); C07D 498/14 (2013.01); C07D 498/22 (2013.01);
Abstract
The present invention relates to tricyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of one or more FGFR enzymes and are useful in the treatment of FGFR-associated diseases such as cancer.